These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4706204)

  • 1. Comparative study of growth hormone response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment.
    Brauman H; Smets P; Corvilain J
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1162-74. PubMed ID: 4706204
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose tolerance, insulin, and growth hormone in thyrotoxicosis and in myxedema.
    Ohlsen PM; Danowski TS; Vidalon C; Ahmad U; Nolan S; Stephan T
    Endocr Res Commun; 1974; 1(5-6):435-48. PubMed ID: 4461267
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of propranolol on plasma growth hormone response in insulin-induced hypoglycemia in thyrotoxic patients.
    Yeung RT
    J Clin Endocrinol Metab; 1973 Dec; 37(6):968-71. PubMed ID: 4753434
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone response to insulin-induced hypoglycemia in thyrotoxicosis.
    Rosenfeld PS; Wool MS; Danforth E
    J Clin Endocrinol Metab; 1969 Jun; 29(6):777-80. PubMed ID: 5783580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum levels of growth hormone in the course of insulin-induced hypoglycemia in hyperthyroidism and hypothyroidism].
    Schneider E
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1311-3. PubMed ID: 1161571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum insulin concentration following oral glucose loading in thyrotoxicosis and myxedema].
    Schneider E
    Endokrynol Pol; 1975; 26(5):507-15. PubMed ID: 1218530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoreactive plasmatic insulin (IRI) in hyperthyreosis and myxedema. Effects of glucose and glucagon in intravenous injection].
    Andreani D; Menzinger G; Fallucca F; Tamburrano G; Aliberti G
    Folia Endocrinol; 1968 Feb; 21(1):18-30. PubMed ID: 5754871
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone and cortisol responses to insulin-induced hypoglycemia in thyrotoxicosis.
    Giustina G; Reschini E; Valentini F; Cantalamessa L
    J Clin Endocrinol Metab; 1971 Apr; 32(4):571-4. PubMed ID: 4926258
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin, glucagon and growth hormone in primary adult myxoedema.
    Andreani D; Fallucca F; Tamburrano G; Iavicoli M; Menzinger G
    Diabetologia; 1974 Feb; 10(1):7-12. PubMed ID: 4835609
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B; Reiner Z; Sekso M
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin levels in thyrotoxicosis and primary myxoedema: response to intravenous glucose and glucagon.
    Andreani D; Menzinger G; Fallucca F; Aliberti G; Tamburrano G; Cassano C
    Diabetologia; 1970 Feb; 6(1):1-7. PubMed ID: 4190847
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissappearance rate of exogenous insulin, insulin sensitivity, responses of plasma growth hormone and cortisol and urinary epinephrine to hypoglycemia in prediabetic subjects.
    Cerasi E; Luft R
    Horm Metab Res; 1969 Jul; 1(4):221-3. PubMed ID: 5407084
    [No Abstract]   [Full Text] [Related]  

  • 13. The response of plasma sugar, free fatty acids, 11-hydroxycorticosteroids and growth hormone to insulin-induced hypoglycaemia and vasopressin in primary myxoedema.
    Vince FP; Boucher BJ; Cohen RD; Godfrey J
    J Endocrinol; 1970 Nov; 48(3):389-400. PubMed ID: 5480889
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin behavior in thyroid disorders of childhood.
    Hayek A; Maloof F; Crawford JD
    Pediatr Res; 1973 Jan; 7(1):28-38. PubMed ID: 4119824
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations concerning the effect of synthetic "thyrotropin releasing factor" (TRF) in patients with thyroid gland function disorders and in healthy controls].
    zur Mühlen A von ; Köbberling J; Hesch RD; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():76. PubMed ID: 4101597
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hormones on glucose metabolism in man. 1. Intravenous glucose tolerance test in normal subjects and patients with various endocrine disorders].
    Morita T
    Naika Hokan; 1971; 18(6):197-211. PubMed ID: 5165208
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of standard intravenous insulin tolerance tests on growth hormone, 11-hydroxycorticosteroids, free fatty acids and plasma sugar in myxoedema.
    Vince FP; Boucher BJ; Cohen RD; Godfrey J; Walters P
    Clin Sci; 1970 Dec; 39(6):17P-18P. PubMed ID: 5493934
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon-initiated human growth hormone release: a comparative study.
    Cain JP; Williams GH; Dluhy RG
    Can Med Assoc J; 1972 Oct; 107(7):617-22. PubMed ID: 4665093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-endorphins in the blood of patients with thyrotoxicosis and myxedema].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1984 Oct; 123(42):1270-2. PubMed ID: 6095997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.